Eklira Genuair

Eklira Genuair Dosage/Direction for Use

Manufacturer:

AstraZeneca

Distributor:

Zuellig
/
Four Star
Full Prescribing Info
Dosage/Direction for Use
Posology: The recommended dose is one inhalation of 322 micrograms aclidinium twice daily.
If a dose is missed the next dose should be taken as soon as possible. However, if it is nearly time for the next dose, the missed dose should be skipped.
Elderly: No dose adjustments are required for elderly patients (see Pharmacology: Pharmacokinetics under Actions).
Renal impairment: No dose adjustments are required for patients with renal impairment (see Pharmacology: Pharmacokinetics under Actions).
Hepatic impairment: No dose adjustments are required for patients with hepatic impairment (see Pharmacology: Pharmacokinetics under Actions).
Paediatric population: There is no relevant use of Eklira Genuair in children and adolescents (under 18 years of age) for the indication of COPD.
Method of administration: For inhalation use.
Patients should be instructed on how to administer the product correctly. (See Instructions for use under Cautions for Usage.)
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in